TY  - JOUR

T1  - Bleeding risk with AZD6140, a reversible P2Y(12) receptor antagonist, vs. clopidogrel in patients undergoing coronary artery bypass grafting in the DISPERSE2 trial

JO  - INT J CLIN PRACT

PY  - 2009/04/01

AU  - Husted S

AU  - Harrington RA

AU  - Cannon CP

AU  - Storey RF

AU  - Mitchell P

AU  - Emanuelsson H

ED  - 

DO  - DOI: 10.1111/j.1742-1241.2009.02030.x

VL  - 63

IS  - 4

SP  - 667

EP  - 670

Y2  - 2024/10/23

ER  -